Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-063)(COMPLETED)
This study has been completed.
Study NCT00034944   Information provided by Merck

First Received on May 2, 2002.   Last Updated on May 20, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Major Depressive Disorder
Additional conditions recognized in this trial
Depression
Depressive Disorder
Depressive Disorder, Major
More general conditions related to this trial
Behavioral Symptoms
Mental Disorders
Mood Disorders
Interventions listed in this trial
MK0869, aprepitant
Comparator: placebo
Additional drug interventions recognized in this trial
Aprepitant
More general drug interventions related to this trial
Antiemetics
Autonomic Agents
Central Nervous System Agents
Gastrointestinal Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services